| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |